Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 3,035.1 | 2,498.2 | 2,197.68 | 1,650.83 | 1,329.94 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,035.1 | 2,498.2 | 2,197.68 | 1,650.83 | 1,329.94 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 42.7 | 16.1 | 40.7 | 29.77 | 10.17 |
Total Income | 3,077.8 | 2,514.3 | 2,238.38 | 1,680.6 | 1,340.1 |
Total Expenditure | 2,252.2 | 1,861.3 | 1,593.67 | 1,135.04 | 959.05 |
PBIDT | 825.6 | 653 | 644.71 | 545.56 | 381.05 |
Interest | 90.3 | 47 | 30.55 | 16.03 | 32.5 |
PBDT | 735.3 | 606 | 614.17 | 529.53 | 348.55 |
Depreciation | 177.2 | 146.5 | 129.26 | 72.67 | 69.54 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 149.5 | 116.2 | 116.61 | 112.89 | 76.84 |
Deferred Tax | -6.2 | 7.4 | 2.48 | 0.17 | -3.3 |
Reported Profit After Tax | 414.8 | 335.9 | 365.81 | 343.8 | 205.48 |
Minority Interest After NP | 30.3 | 25.9 | 29.49 | 11.11 | 4.26 |
Net Profit after Minority Interest | 384.5 | 310 | 336.32 | 332.69 | 201.22 |
Extra-ordinary Items | 7.91 | 0 | 11.19 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 376.59 | 310 | 325.13 | 332.69 | 201.22 |
EPS (Unit Curr.) | 9.61 | 38.75 | 42.03 | 41.88 | 26.87 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 80 | 80 | 80.03 | 80.03 | 77.59 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 27.2 | 26.13 | 29.33 | 33.04 | 28.65 |
PBDTM(%) | 24.22 | 24.25 | 27.94 | 32.07 | 26.2 |
PATM(%) | 13.66 | 13.44 | 16.64 | 20.82 | 15.45 |
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.